What Is Melanotan 1?
Melanotan 1 research has established this alpha-MSH analogue as the gold standard MC1R-selective agonist for melanogenesis and photoprotection research — combining extraordinary MC1R selectivity with sufficient metabolic stability for chronic research protocols, and providing the foundation for the only FDA-approved melanocortin therapy for a photodermatological condition (Scenesse for erythropoietic protoporphyria).
Melanotan 1 (Afamelanotide, [Nle4, D-Phe7]-α-MSH, molecular weight approximately 1,646 Da) is a synthetic linear analogue of alpha-melanocyte stimulating hormone (α-MSH), developed at the University of Arizona by Mac Hadley and Victor Hruby. Two key amino acid substitutions distinguish it from the native α-MSH sequence: replacement of methionine at position 4 with norleucine (Nle4) — eliminating the oxidation-prone sulfur-containing side chain — and substitution of L-phenylalanine at position 7 with D-phenylalanine (D-Phe7) — locking the peptide into a bioactive β-turn conformation that dramatically increases receptor binding affinity and metabolic stability. These modifications produce a compound with substantially greater potency and duration of action than native α-MSH while maintaining high selectivity for MC1R over other melanocortin receptor subtypes.
Mechanism of Action
Selective MC1R Agonism
Melanotan 1’s defining pharmacological characteristic is its high selectivity for melanocortin 1 receptor (MC1R) — the primary receptor responsible for skin and hair pigmentation through stimulation of melanogenesis in melanocytes. MC1R is expressed predominantly in melanocytes, with lower expression in immune cells, keratinocytes, and select CNS regions. This peripheral selectivity profile — contrasting sharply with Melanotan 2’s non-selective pan-melanocortin activity — means Melanotan 1 can be used to study MC1R-specific biology without the confounding MC3R/MC4R-mediated CNS and autonomic effects that accompany Melanotan 2 research.
Eumelanin Synthesis Stimulation
MC1R activation in melanocytes drives the switch from phaeomelanin (yellow-red, UV-sensitive) to eumelanin (brown-black, UV-protective) synthesis. This pigment switch is mediated through a cAMP-dependent transcriptional cascade: MC1R → Gs → adenylyl cyclase → cAMP → PKA activation → CREB phosphorylation → MITF (microphthalmia-associated transcription factor) upregulation → transcription of melanogenic enzymes (tyrosinase, TYRP1, DCT). Research has examined this entire pathway using Melanotan 1 as the MC1R activating stimulus, allowing precise dissection of each step in the eumelanin synthesis cascade.
Photoprotective Mechanisms
Beyond simply increasing melanin production, MC1R activation drives multiple photoprotective mechanisms in melanocytes and keratinocytes. Eumelanin itself absorbs UV radiation and quenches reactive oxygen species generated by UV exposure — physically protecting nuclear DNA from photodamage. Additionally, MC1R activation upregulates DNA repair enzyme expression — particularly nucleotide excision repair (NER) pathway components — enhancing the cell’s capacity to repair UV-induced pyrimidine dimers and 6-4 photoproducts. Research has examined these UV-independent photoprotective mechanisms as potential targets for melanoma prevention research.
Anti-Inflammatory Activity Through MC1R
MC1R expressed on immune cells — particularly macrophages, dendritic cells, and T lymphocytes — mediates anti-inflammatory effects of alpha-MSH family peptides. MC1R activation suppresses NF-κB signaling, reduces pro-inflammatory cytokine production (TNF-α, IL-1β, IL-6), and promotes anti-inflammatory mediator release. Research has examined Melanotan 1’s immune-modulatory effects in models of skin inflammation, inflammatory skin conditions, and systemic inflammatory disease — investigating whether MC1R-mediated anti-inflammation is a mechanism contributing to its documented effects beyond simple melanogenesis.
Melanocyte Survival and Proliferation
MC1R activation promotes melanocyte survival — anti-apoptotic signaling downstream of cAMP/PKA protects melanocytes from UV-induced apoptosis and oxidative stress-induced cell death. Research has examined whether this melanocyte survival effect could be relevant to conditions involving melanocyte loss, and whether it interacts with the tumorigenicity risk in melanocyte populations — a complex research question with implications for understanding MC1R’s dual role in photoprotection and melanoma biology.
Research Applications
Melanogenesis and Pigmentation Biology Research
Melanotan 1 is the definitive research tool for studying MC1R-specific melanogenesis — the complete pathway from receptor activation to eumelanin deposition. Research has used it to dissect each step of this pathway: MC1R signal transduction, MITF regulation, tyrosinase activation kinetics, melanosome biogenesis and transfer, and the relationship between melanin type (eumelanin vs phaeomelanin) and UV protection. These studies are foundational to understanding skin pigmentation biology and its relationship to photoprotection and skin cancer risk.
Photoprotection and Melanoma Prevention Research
The relationship between MC1R genotype, melanogenesis capacity, UV sensitivity, and melanoma risk is one of the most intensively studied topics in dermatology research. Loss-of-function MC1R variants are among the strongest known risk factors for melanoma — individuals with certain MC1R polymorphisms have dramatically impaired eumelanin synthesis capacity and correspondingly elevated melanoma risk. Melanotan 1 provides a research tool for pharmacologically activating MC1R in cells and animals with varying MC1R genotypes — investigating whether exogenous MC1R agonism can overcome genetic eumelanin synthesis deficits and provide UV protection benefits. Melanotan 1 (as Afamelanotide) is FDA-approved for erythropoietic protoporphyria — a photodermatological condition where light exposure causes severe pain due to protoporphyrin accumulation — providing clinical validation of MC1R agonism as a photoprotection strategy.
Inflammatory Skin Condition Research
MC1R’s anti-inflammatory activity in skin immune cells and keratinocytes has made Melanotan 1 a research tool for inflammatory dermatology models. Studies have examined its effects in models of psoriasis, contact dermatitis, and UV-induced skin inflammation — investigating whether pharmacological MC1R activation can reduce inflammatory skin pathology through immune cell-directed mechanisms independent of melanogenesis.
Comparative Melanocortin Receptor Research
The availability of Melanotan 1 (MC1R-selective), PT-141 (MC3R/MC4R-selective), and Melanotan 2 (pan-melanocortin) at AminoForge enables parallel arm research designs that systematically isolate the contributions of each melanocortin receptor subtype to any observed biological outcome — a powerful experimental approach for establishing receptor-specific mechanistic attribution in melanocortin system research.
DNA Repair and Genomic Stability Research
MC1R activation’s documented upregulation of nucleotide excision repair pathway components makes Melanotan 1 relevant to research on UV-induced DNA damage and repair. Studies have examined whether MC1R-driven NER enhancement can reduce UV mutation rates — particularly at melanoma hotspot positions — providing mechanistic data on how MC1R contributes to photocarcinogenesis protection beyond simple UV absorption by melanin.
Melanotan 1 in the AminoForge Melanocortin Research Catalog
Melanotan 1 is the MC1R-selective reference compound in AminoForge’s melanocortin research catalog. Researchers investigating melanocortin receptor biology will find it most productive when studied in parallel with Melanotan 2 — the pan-melanocortin agonist precursor that activates MC1R, MC3R, MC4R, and MC5R simultaneously — and PT-141 (Bremelanotide), which provides selective MC3R/MC4R CNS activity with minimal MC1R melanogenesis. This three-compound melanocortin toolkit enables systematic receptor-specific research across the full melanocortin system. For skin biology research combining melanocortin and collagen/extracellular matrix mechanisms, GHK-Cu offers complementary skin biology mechanisms. For further reading see: Melanotan 1 MC1R selectivity and melanogenesis research (PubMed).
Shop Melanotan 1 at AminoForge — ≥99% purity, third-party COA verified, USA manufactured, ships within 48 hours.
Formulation and Storage
Melanotan 1 is available as a lyophilized powder. With a molecular weight of approximately 1,646 Da, it is a mid-sized linear peptide with enhanced stability over native α-MSH due to the Nle4 and D-Phe7 modifications. Standard storage at −20°C for lyophilized powder applies, with reconstituted solutions stored at 2–8°C and protected from light. Bacteriostatic water is the standard reconstitution vehicle. Research-grade purity should be verified at ≥99% by HPLC with mass spectrometry confirmation of the 1,646 Da molecular weight and the correct [Nle4, D-Phe7] modified sequence.
All products sold by AminoForge are intended exclusively for laboratory and research purposes. Not for human or veterinary consumption. Researchers are responsible for compliance with all applicable laws and regulations governing research compound use in their jurisdiction.